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Cultural adaptation and psychometric
evaluation of the Swedish version of the
Reproductive Concerns After Cancer (RCAC)
scale
Poorna Anandavadivelan1* , Maria Wiklander2, Lars E. Eriksson3,4,5, Lena Wettergren1 and Claudia Lampic1,6
Abstract
Background: Reproductive concerns are common among young cancer survivors and include worries related to
different aspects of fertility and parenthood. The Reproductive Concerns After Cancer (RCAC) scale is an 18-item
scale with six dimensions, developed to capture a variety of such concerns. The aim of the present study was to
describe the cultural adaptation of the RCAC scale into Swedish and evaluate its psychometric properties among
young women who have undergone treatment for cancer.
Methods: The RCAC was forward translated from English into Swedish and assessed for cultural adaptation based
on a two-panel approach followed by cognitive interviews with the target group. For the psychometric evaluation,
a Swedish cohort of 181 female young adult breast cancer survivors completed a survey including the RCAC scale
approximately 1.5 years post-diagnosis. Psychometric properties were examined by analyses of construct validity
(confirmatory factor analysis and convergent validity), data quality (score distribution, floor and ceiling effects),
reliability and known-groups validity.
Results: The confirmatory factor analysis yielded an acceptable fit (RMSEA 0.08, SRMR 0.09, CFI 0.92). Convergent
validity was demonstrated by a negative correlation of moderate size (− 0.36) between the RCAC total score and
the emotional function scale of the EORTC QLQ-C30. Reliability measured with Revelle Ω total was satisfactory
(0.73–0.92) for five of the dimensions, and poor for the dimension Becoming pregnant (Revelle Ω total = 0.60);
Cronbach’s alpha showed a similar pattern. Known-groups validity was indicated by significant RCAC mean score
differences (MD), reflecting more concerns among women with a certain (MD 4.56 [95% CI 3.13 to 5.99]) or
uncertain (MD 3.41 [95% CI 1.68 to 5.14]) child wish compared to those with no wish for (additional) children.
(Continued on next page)
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: poorna.anandavadivelan@ki.se
1Department of Women’s and Children’s Health, Karolinska Institutet, Solna,
Sweden
Full list of author information is available at the end of the article
Anandavadivelan et al. Health and Quality of Life Outcomes          (2020) 18:273 
https://doi.org/10.1186/s12955-020-01520-y
(Continued from previous page)
Conclusion: The translation and cultural adaptation of the Swedish RCAC has resulted in a scale demonstrating
construct and known-groups validity, and satisfactory reliability for five of six dimensions. The dimension Becoming
pregnant showed non-optimal internal consistency and should undergo further evaluation. The Swedish RCAC is
recommended to be used in research settings for measurement of concerns related to fertility and parenthood in
young women with cancer.
Keywords: Breast neoplasms, Fertility distress, Psychometric evaluation, Reproductive health, Survivorship,
Translation
Background
A large number of individuals in the age bracket 18–39,
defined as young adults [1], are diagnosed with cancer
worldwide. In the United States alone, around 60,000
young adults are diagnosed with cancer yearly [2] and,
correspondingly in Sweden, around 2000 young adults
face a cancer diagnosis every year [3]. The cancer itself,
or being exposed to surgical and/or gonadotoxic treat-
ments may result in temporary or permanent infertility,
or sub-fertility in young adult survivors [4], many of
whom may not have had the possibility to start or
complete their family prior to their cancer diagnosis.
Young adult cancer survivors report a number of repro-
ductive concerns after treatment, including worry
regarding the ability to have children in the future, fears
about recurrence, their child’s health and their own
health [5, 6]. Among female cancer survivors, a wish for
(additional) children has been shown to be associated
with more worries about infertility [7]. Furthermore,
higher levels of reproductive concerns have been found
to be associated with poorer quality of life and depres-
sion [8].
To capture the full range of reproductive concerns
following cancer the multidimensional Reproductive Con-
cerns After Cancer (RCAC) scale was developed for use in
young adult female survivors [7]. The scale has shown sat-
isfactory construct validity and internal consistency
among women aged 18–44 treated for different types of
cancer in the United States [7, 9]. Outside the US context,
the RCAC scale has been translated and culturally adapted
into Chinese [10] and Portuguese [11], demonstrating
suitable psychometric properties for evaluation of repro-
ductive concerns in young patients with cancer.
The aim of the present study was to describe the transla-
tion and cultural adaptation of the RCAC scale into Swed-
ish and to evaluate its psychometric properties among
young women with breast cancer, using data collected in an
earlier study [12].
Methods
The RCAC scale
The RCAC scale consists of 18 items that constitute six
dimensions: Fertility potential, Partner disclosure, Child’s
health, Personal health, Acceptance, and Becoming preg-
nant. Each dimension has three items with responses
scored on a five-point scale (ranging from 1 = Strongly
disagree to 5 = Strongly agree), with higher scores indi-
cating higher levels of reproductive concerns [7]. The
psychometric properties of the original scale in English
showed that the internal consistency of the total RCAC
scale was good (α =0.82), and good or acceptable for the
six sub-scales (α = 0.78–0.86) [7]. Known-groups validity
was demonstrated by significantly higher mean scores
among women who wanted to have children compared
to those who did not, and among those for whom having
a biological child was very important compared to those
for whom it was less important [7]. Total RCAC scores
were positively associated with depression and negatively
associated with social support and satisfaction with life.
Swedish translation and cultural adaptation of the
Swedish RCAC scale
For the purpose of use in a study from our research
group [12], the original RCAC scale was translated and
culturally adapted to be able to measure reproductive
concerns in a Swedish context. To achieve this, the scale
was forward translated into Swedish based on a dual
panel approach and further assessed for cultural adapta-
tion by lay panel, patient/target group assessment and
cognitive interviews [13]. The process of translation and
cultural adaptation was coordinated by the same coord-
inator to ensure none of the parameters were neglected
and to maintain the quality of the adaptation.
Forward translation by bilingual expert panel
The RCAC scale was translated from English to Swedish
by two researchers who were native Swedish speakers
and well-versed in English. The first translator (T1) had
extensive research knowledge in the field of fertility and
cancer. The second translator (T2) coordinated the
translation and was experienced in instrument transla-
tion and adaptation, but was not knowledgeable in the
research fields of fertility and cancer. Both researchers
had broad experience of clinical work with diverse
patient groups. Following individually performed trans-
lations of the scale, T1 and T2 discussed discrepancies
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between the two versions. As a next step, they con-
sulted the principal investigator of the original English
version of the RCAC to discuss and clarify the intended
conceptual meaning of the scale and specific items.
Subsequently, the two translators (T1 and T2) and two
additional experts in the field of psychosocial oncology
(native Swedish speakers) discussed the translation in a
panel meeting. As a result, a consensus version of the
Swedish version of the RCAC was created. Cultural
adaptation included changing the use of “spouse/part-
ner” in the three items of the dimension Partner dis-
closure to “partner”, as this was deemed more
appropriate for use in the Swedish context where it is
common for two adults to live together without being
married.
Lay panel assessment
For evaluation of the translated version of the scale,
two lay panels were recruited through personal con-
tacts and local advertisements. The panel members
were 3 women and 4 men between 18 and 41 years
old; three had secondary education and four had
higher education. Two had children and none of the
panel members had been diagnosed with cancer.
Panel members were compensated with cinema tickets
for their participation. The lay panels were only pro-
vided with the Swedish version of the scale, as sug-
gested [13]. The lay panel members were instructed
to go through all parts of the RCAC scale, including
instructions, items and response options. Everyone
read each item, then discussed how they perceived
the issue and whether there were any alternative ways
of phrasing the question. Based on the assessment by
the lay panels, minor changes in wording were made.
The main role of the lay panels was to produce a ver-
sion that was easy to understand for the average
Swedish speaking person. The lay panel assessment
was led by the same coordinator as for the expert
panel.
Patient/target group assessment
The patient/target group included 5 women and 3
men (aged 20–41) who had been treated for cancer.
The target group members came from different geo-
graphical areas in Sweden and all had secondary or
higher education. They evaluated the translated RCAC
scale for face validity i.e., if the items and response
alternatives were relevant and acceptable. Some con-
cerns were expressed regarding the suitability and
relevance of the scale for patients in their late teens,
which led us to conducting cognitive interviews as
described below. The target group members were
compensated for their travel costs and time spent.
Cognitive interviews
Cognitive interviews were performed individually with 3
young individuals (1 female aged 18 years and 2 males
aged 17 years) currently being treated for cancer. The
participants completed the Swedish RCAC scale and
were then interviewed on their experience of responding
to the items. We used a flexible approach as suggested
earlier [14]. In brief, respondents were asked to think
aloud and share thoughts, perceptions and opinions that
came up when answering the questions. The interviewer
probed every issue that was mentioned to capture diffi-
culties related to the items of the RCAC. We asked if
items were difficult to understand (wording, knowledge
requested and information given), included inappropri-
ate assumptions, were too sensitive (content, wording
and social acceptability), as well as if the response
categories were adequate.
Psychometric evaluation
Participants and procedure
A detailed description of the study participants and pro-
cedure is presented elsewhere [12]. Briefly, a sample of
301 women consecutively diagnosed with invasive breast
cancer (all stages except in-situ and very few with distant
metastasis) at age 18–39 years was identified from the
Swedish National Quality Register for Breast Cancer.
Data collection was conducted by means of a compre-
hensive postal survey approximately 1.5 years post-
diagnosis. Ethical approval for the study was obtained
from the Regional Ethical Review Board in Stockholm,
Sweden (Ref No: 20131746–31/4).
Additional measures
The survey completed by the participants comprised
several patient-reported outcome measures. For the
purpose of the psychometric evaluation of the Swedish
version of the RCAC, the Emotional Function (EF) scale
of the EORTC QLQ-C30 version 3.0 [15] and a study-
specific item regarding current wish to have (additional)
children (response alternatives: Yes, Uncertain, No) were
used from the survey.
Statistical analysis
Statistical analysis was performed using SPSS statistics
for Windows, version 24 (IBM Corp., Armonk, N.Y.,
USA) and IBM® SPSS® Amos, version 25 and R version
4.0.0 (The R Foundation for Statistical Computing) with
the additional R package ‘userfriendlyscience’ [16]. For
all statistical tests, the level of statistical significance was
defined as p < 0.05.
Construct validity was ascertained using Confirmatory
factor analysis (CFA) and convergent validity. CFA with
maximum likelihood estimation was performed to deter-
mine the adequacy of the original six-factor structure of
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the RCAC on our sample data [7]. Four participants
were excluded from the CFA due to not having com-
pleted the RCAC scale (n = 3) or missing values for 2
items in one dimension (n = 1). Missing values for single
items (n = 15) were handled by imputing the mean of
the other two items of the same individual in the same
dimension. Standardized factor loadings and model fit
were determined from the CFA. Standardized factor
loadings of ≥ 0.4 were considered as acceptable as deter-
mined from the CFA [17]. Model fit was estimated by
two absolute indices of overall model fit, Root mean
square error of approximation (RMSEA) and Standard-
ized root mean residual (SRMR), and one relative index
of model fit compared to the null model, Comparative
fit index (CFI). The acceptable thresholds for these indi-
ces were defined as RMSEA: 0.05–0.08, SRMR: < 0.10
and CFI: > 0.90 according to Kline’s [18] guidelines. The
model chi-square (χ2), degrees of freedom (d.f.) and as-
sociated p value were reported, but were not considered
as an indicator of model fit owing to their restrictiveness
by being sensitive to sample size [19]. Additionally, the
relative/normed χ2 ratio (χ2/d.f.) was also reported as
recommended, and a cut-off value of < 5 was regarded
as good [20]. Convergent validity was assessed by calcu-
lating the Pearson correlation coefficient for the mean
scores of the Swedish RCAC scale and the EF scale of
the EORTC QLQ-C30. The EF scale covers both symp-
toms of anxiety and depression and is a robust measure
of emotional distress in patients with cancer [21]. The
construct represented by the EF was thus expected to be
related to RCAC scores although it is distinct from that
of reproductive concerns. We hypothesized that RCAC
total scores would show a negative association of moder-
ate size with EF (higher scores of the scale indicate bet-
ter EF). Correlation coefficients of 0.10–0.29, 0.30–0.49
and 0.50 and above were interpreted as small, moderate
and large, respectively [22, 23].
Data quality was assessed by examination of missing
values, mean scores, standard deviations (SD), and floor
and ceiling effects. Floor and ceiling effects were consid-
ered present if > 15% rated at the lowest (floor) and
highest (ceiling) scores [24].
Reliability was assessed by means of the internal
consistency of the six dimensions using Cronbach’s α as
well as Ω total and Revelle Ω total [25]; values of ≥ 0.70
were considered acceptable [26].
Known-groups validity was assessed by comparing
groups of women who differed in their reported wish for
children or additional children. It was hypothesised that
women with a wish for children would report higher
levels of reproductive concerns than those without such
a wish, in line with previous reports [7, 27]. A one-way
ANOVA with post-hoc comparisons using the Tukey
test was conducted to compare the mean scores of the
Swedish RCAC scale of the three groups of women who
reported a certain, uncertain or no wish for (additional)
children respectively.
Results
Sample characteristics
Of 301 eligible women, 181 completed the survey
(response rate 60%). Demographic and clinical charac-
teristics of the participants are presented in detail
elsewhere [12]. Briefly, mean age was 36.5 (SD 4.1, range
23–42), a majority had children (77%) and were in a
current partner relationship (87%). A wish for (add-
itional) children was expressed by 36% of the women,
20% were uncertain and 44% had no current child wish.
Construct validity
Confirmatory factor analyses
The CFA with maximum likelihood estimation was per-
formed on the responses of 177 participants with
complete data after imputation of missing values. The
CFA provided a relative/normed χ2 value of 2.06 (χ2 =
246.543; degrees of freedom = 120; p < 0.001). The CFA
provided an RMSEA of 0.08 (90% CI 0.06–0.09), an
SRMR value of 0.09 and a CFI of 0.92, indicating an ac-
ceptable fit. Standardized factor loading estimates ranged
from 0.43 to 0.94 and were above the acceptable factor
loading cut-off (Fig. 1). Standardized factor loadings
were statistically significant (p < 0.01) for all six of the
dimensions (data not shown).
Convergent validity
The Swedish RCAC total scale score and the EF scale of
the EORTC QLQ-C30 showed a negative correlation
with a correlation coefficient of moderate size (r − 0.36).
Data quality
Descriptive statistics of the RCAC dimensions are
presented in Table 1. There were few missing responses
(< 1%/ item). Item means and standard deviations within
dimensions were roughly equivalent with one exception,
means of the items of the Personal health dimension
had a slightly wider range (2.67 to 4.12); all response
alternatives were used for all items. A floor effect above
the customary cut-off of 15% was observed in the
dimensions Fertility potential (21%), Partner disclosure
(34.3%) and Becoming pregnant (17.1%). A ceiling effect
(> 15%) was detected in the dimension Child’s health
(17.7%).
Reliability
The Ω total and Revelle Ω total were above considered
acceptable (≥ 0.70) for five of the six dimensions, and
poor for the dimension Becoming pregnant (Ω total
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0.58, Revelle Ω total 0.60; 95% CI 0.42–0.66), see Table
1; the Cronbach’s alpha showed a similar pattern.
Known-groups validity
The results for the known-groups validity investigation
showed a significant difference in RCAC total mean
scores between the three groups based on self-reported
child wish (F = 29.54, p < 0.001). Statistically significant
group differences were found between, on the one hand,
women with a wish for (additional) children and, on the
other hand, women who were uncertain if they wanted
children (MD 3.41; 95% CI 1.68–5.14) and women who
had no child wish (MD 4.56; 95% CI 3.13–5.99). No sta-
tistically significant difference in RCAC scores was ob-
served between the latter two groups (uncertain vs no
child wish) (MD 1.15; 95% CI − 0.53 to 2.82).
Discussion
In the present study, the psychometric properties of the
Swedish RCAC scale were evaluated in young survivors
Fig. 1 CONFIRMATORY Factor Analysis model of the Swedish RCAC scale on a sample of 177 breast cancer survivors
Table 1 Descriptive statistics and internal reliability of the six RCAC dimensions
Dimension Mean (SD) Range of item means (SD) Floor/ceiling
effects (%)
α
(95% CI)
Ω Total
(95% CI)
Revelle Ω
Total
Fertility Potential 2.75 (1.32) 2.67–2.91 (1.36–1.46) 21.0/7.2 0.92 (0.89–0.94) 0.92 (0.90–0.94) 0.92
Partner disclosure 2.17 (1.12) 2.07–2.28 (1.22–1.27) 34.3/2.2 0.88 (0.84–0.91) 0.88 (0.85–0.91) 0.88
Child’s health 3.58 (1.21) 3.48–3.69 (1.32–1.40) 6.1/17.7 0.84 (0.80–0.88) 0.85 (0.81–0.89) 0.85
Personal health 3.27 (1.06) 2.76–4.12 (1.24–1.41) 5.0/7.7 0.68 (0.60–0.76) 0.73 (0.66–0.80) 0.73
Acceptance 2.44 (1.09) 2.33–2.57 (1.22–1.38) 13.3/3.9 0.78 (0.72–0.84) 0.78 (0.73–0.84) 0.79
Becoming pregnant 2.41 (0.90) 2.33–2.53 (1.19–1.27) 17.1/2.2 0.54 (0.42–0.66) 0.58 (0.47–0.68) 0.60
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of breast cancer while retaining the same factor struc-
ture as the original version of the scale. The translated
and culturally adapted scale demonstrated face validity
in evaluation with experts and persons from the target
group. The CFA provided an acceptable fit and all
dimensions except Becoming pregnant displayed satis-
factory reliability. Convergent validity was demonstrated
by a moderate negative association with emotional func-
tion, and known-groups validity was shown by statisti-
cally significant differences in RCAC scores between
groups with and without a wish for (additional) children.
The present results demonstrated reasonable evidence
to support the six-factor structure of the Swedish RCAC.
Although differences between the strength of model fit
indices were observed for the Swedish version of the
RCAC, the Chinese RCAC scale [10] and the re-
validated RCAC scale [9], an overall comparison of con-
struct validity showed compliance with the six-factor
structure of the original RCAC [7] consistently across all
studies. However, in a recent study describing the Portu-
guese RCAC, explanatory factor analysis led to a five-
factor structure [11]. In the present study the RMSEA
was within an acceptable level of error of approximation,
the SRMR value was slightly outside the suggested range
although not pointing to a poor fit, and the CFI indi-
cated a reasonably good fit [18]. It must be noted that
while some fit indices may point to a well-fitting model,
parts of the fit indices may show non-optical figures
[19]. This, together with the fact that there are multiple
and not rigid guidelines available for ”acceptable” model
fit [20], makes us conclude that our analyses overall
show that the model has an acceptable fit. However,
even though the sample size of our study met the rule of
thumb for CFA given a non-complex model [18], future
studies with larger samples are needed to validate our
findings for the Swedish RCAC.
As expected, the Swedish RCAC demonstrated a nega-
tive moderate association with the EF subscale of the
EORTC QLQ-C30. This finding was consistent with pre-
vious studies showing that high levels of the RCAC are
associated with lower levels of emotional function [11],
social support and satisfaction with life [25]. These re-
sults are also in line with previous reports that higher
RCAC scores are associated with anxiety and depression
[7, 10, 11]. The present and previous results [7, 10, 11]
indicate that reproductive concerns, as measured by the
RCAC, represent a construct that is related to but dis-
tinct from anxiety and depression.
The differences with regard to the strength of the
model fit indices and convergent validity may be attrib-
uted to differences in the sampling techniques between
the studies. In the studies describing the original RCAC,
participants were recruited via social media outreach
and fertility preservation programs [7, 9] and the study
of the Portuguese RCAC used convenience sampling
[11]. This may have resulted in an overrepresentation of
female cancer survivors interested in having children, as
also pointed out by some of the researchers. While the
population-based sample in our study may be regarded
as more representative for survivors of breast cancer
owing to a lower risk of selection bias, the socio-
demographics of the sample differed from those in previ-
ous studies. In comparison to the studies mentioned
above [7, 11], larger proportions of women in the
present study were currently in a partner relationship,
already had children and had no wish for (additional)
children. Hence it is not surprising that many
participants chose the lowest possible scores for the
dimensions Partner disclosure, Fertility potential and
Becoming pregnant, resulting in floor effects. Similarly, a
ceiling effect was seen for the subscale Child’s health
that focuses on concerns related to a potential hereditary
risk of cancer for offspring. This finding may be attrib-
uted to the fact that the present sample consisted of
women diagnosed with breast cancer under the age of
40, who are at higher risk of hereditary cancer gene mu-
tations [28]. Thus, in comparison to previous studies of
the RCAC that included lower percentages of breast
cancer survivors [7, 9, 11], more women in our cohort
may have had reason to be concerned about a genetic
cancer risk for their children.
Known-groups validity of the Swedish RCAC was
shown by significantly higher levels of reproductive
concerns among women who wanted to have children
compared to those without a child wish, as hypothesised.
These results are in line with those reported for the
original RCAC [7] and recently for the Portuguese
version of the RCAC [11].
Reliability, exhibited by Ω, was above the acceptable
range in five of the six dimensions. Only the Becoming
pregnant dimension was below the acceptable limit in
our study. These results are similar to the results of the
psychometric validation of the original RCAC scale [9].
In the explanatory factor analysis of the Portuguese ver-
sion of the scale the dimension Becoming pregnant was
not replicated as per the six-factor model, but its items
loaded on two different factors [11]. These results may
suggest that the items in Becoming pregnant are likely
more difficult to comprehend and/or that this dimension
does not capture an equally clear construct as the other
dimensions. This also emphasises the need to consider
testing other psychometric validation methods besides
factor analysis, such as item response theory (IRT), to
analyse the properties of the RCAC instrument in future
studies.
A particular strength of the design of the present study
is the nationwide population-based sample of young
adult breast cancer survivors identified from a valid
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national quality register, which minimised selection bias
related to reproductive concerns. Also, the translation
of the Swedish version of the RCAC scale was con-
ducted based on a dual panel approach [13]. Although
back translation is still considered the gold standard,
dual panel methodology has been shown to perform
equally well and to also have specific linguistic advan-
tages [13, 29].
Conclusions
The translation and cultural adaptation of the Swedish
RCAC has resulted in a scale demonstrating construct
and known-groups validity, and satisfactory reliability for
five of six dimensions. In line with previous studies the
dimension Becoming pregnant showed non-optimal in-
ternal consistency and the dimension is recommended
to undergo further evaluation. Based on the overall re-
sults, with the exception of the Becoming pregnant di-
mension, the Swedish RCAC is recommended to be
used in research settings for measurement of concerns
related to fertility and parenthood in young women with
cancer. The knowledge generated from such studies may
be useful for identification of vulnerable groups through-
out the cancer survivorship trajectory.
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